Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dosimetry based on 99mTc-macroaggregated albumin SPECT/CT accurately predicts tumor response and survival in hepatocellular carcinoma patients treated with 90Y-loaded glass microspheres: preliminary results.
Garin E, Lenoir L, Rolland Y, Edeline J, Mesbah H, Laffont S, Porée P, Clément B, Raoul JL, Boucher E. Garin E, et al. Among authors: clement b. J Nucl Med. 2012 Feb;53(2):255-63. doi: 10.2967/jnumed.111.094235. J Nucl Med. 2012. PMID: 22302962 Free article.
Personalized dosimetry with intensification using 90Y-loaded glass microsphere radioembolization induces prolonged overall survival in hepatocellular carcinoma patients with portal vein thrombosis.
Garin E, Rolland Y, Edeline J, Icard N, Lenoir L, Laffont S, Mesbah H, Breton M, Sulpice L, Boudjema K, Rohou T, Raoul JL, Clement B, Boucher E. Garin E, et al. Among authors: clement b. J Nucl Med. 2015 Mar;56(3):339-46. doi: 10.2967/jnumed.114.145177. Epub 2015 Feb 12. J Nucl Med. 2015. PMID: 25678490 Free article.
Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach: phantom validation and clinical preliminary results in patients with complex hepatic vascularization treated with yttrium-90-labeled microspheres.
Garin E, Lenoir L, Rolland Y, Laffont S, Pracht M, Mesbah H, Porée P, Ardisson V, Bourguet P, Clement B, Boucher E. Garin E, et al. Among authors: clement b. Nucl Med Commun. 2011 Dec;32(12):1245-55. doi: 10.1097/MNM.0b013e32834a716b. Nucl Med Commun. 2011. PMID: 21862941
Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept.
Garin E, Lenoir L, Edeline J, Laffont S, Mesbah H, Porée P, Sulpice L, Boudjema K, Mesbah M, Guillygomarc'h A, Quehen E, Pracht M, Raoul JL, Clement B, Rolland Y, Boucher E. Garin E, et al. Among authors: clement b. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1057-68. doi: 10.1007/s00259-013-2395-x. Epub 2013 Apr 24. Eur J Nucl Med Mol Imaging. 2013. PMID: 23613103 Free PMC article.
Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis.
Edeline J, Crouzet L, Campillo-Gimenez B, Rolland Y, Pracht M, Guillygomarc'h A, Boudjema K, Lenoir L, Adhoute X, Rohou T, Boucher E, Clément B, Blanc JF, Garin E. Edeline J, et al. Among authors: clement b. Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):635-43. doi: 10.1007/s00259-015-3210-7. Epub 2015 Oct 12. Eur J Nucl Med Mol Imaging. 2016. PMID: 26455499
527 results